These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31071350)

  • 1. Preventable Cancer Deaths Associated with Bladder Preservation for Muscle Invasive Bladder Cancer.
    Herr H
    Urology; 2019 Aug; 130():20-21. PubMed ID: 31071350
    [No Abstract]   [Full Text] [Related]  

  • 2. Bladder function preservation with brachytherapy, external beam radiation therapy, and limited surgery in bladder cancer patients: Long-term results [corrected].
    Aluwini S; van Rooij PH; Kirkels WJ; Boormans JL; Kolkman-Deurloo IK; Wijnmaalen A
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):611-7. PubMed ID: 24411629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder sparing surgery in high-grade bladder cancer.
    Yakovlev PG; Klyushin DA; Vereshchako RI
    Exp Oncol; 2019 Jun; 41(2):160-165. PubMed ID: 31262149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomograms predicting response to therapy and outcomes after bladder-preserving trimodality therapy for muscle-invasive bladder cancer.
    Coen JJ; Paly JJ; Niemierko A; Kaufman DS; Heney NM; Spiegel DY; Efstathiou JA; Zietman AL; Shipley WU
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):311-6. PubMed ID: 23474117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder Preservation for Patients With Bladder Paragangliomas: Case Series and Review of the Literature.
    Wang EY; Pak JS; Virk RK; Anderson CB; Healy KA; Lee JA; Benson MC; McKiernan JM
    Urology; 2020 Sep; 143():194-205. PubMed ID: 32437773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of repeat radical transurethral resection for selected patients with muscle-invasive bladder cancer.
    Li Z; Li Y; Lu Q; Chen J
    ANZ J Surg; 2018 Oct; 88(10):1033-1036. PubMed ID: 29974604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder preservation strategy based on combined therapy in patients with muscle-invasive bladder cancer: management and results at long-term follow-up.
    Villavicencio H; Rodriguez Faba O; Palou J; Gausa L; Algaba F; Marcuello E
    Urol Int; 2010; 85(3):281-6. PubMed ID: 20689253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-arterial chemotherapy for muscle-invasive bladder cancer following transurethral resection.
    Liang S; Zou Q; Han B; Jing Y; Cui D; An X; Gao Y; Hu J; Xia S
    Urol Int; 2015; 94(4):406-11. PubMed ID: 25678415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer.
    Cahn DB; Handorf EA; Ghiraldi EM; Ristau BT; Geynisman DM; Churilla TM; Horwitz EM; Sobczak ML; Chen DYT; Viterbo R; Greenberg RE; Kutikov A; Uzzo RG; Smaldone MC
    Cancer; 2017 Nov; 123(22):4337-4345. PubMed ID: 28743162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of organ preservation in patients with small cell carcinoma of the bladder.
    Eswara JR; Heney NM; Wu CL; McDougal WS
    Urol Int; 2015; 94(4):401-5. PubMed ID: 25660255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
    Kukreja JB; Porten S; Golla V; Ho PL; Noguera-Gonzalez G; Navai N; Kamat AM; Dinney CPN; Shah JB
    Eur Urol Focus; 2018 Sep; 4(5):720-724. PubMed ID: 28753837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
    Zhang M; Tao R; Zhang C; Shen Z
    Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.
    Ploussard G; Daneshmand S; Efstathiou JA; Herr HW; James ND; Rödel CM; Shariat SF; Shipley WU; Sternberg CN; Thalmann GN; Kassouf W
    Eur Urol; 2014 Jul; 66(1):120-37. PubMed ID: 24613684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle Invasive Bladder Cancer (MIBC) - The Gold Standard Radical Cystectomy or Bladder Preserving Approach, YES or NO?
    Mahmud SM
    J Pak Med Assoc; 2018 Oct; 68(10):1425-1426. PubMed ID: 30317334
    [No Abstract]   [Full Text] [Related]  

  • 15. [OUTCOME OF BLADDER PRESERVATION USING LOW DOSE CHEMORADIATION THERAPY IN PATIENTS WITH LOCALLY INVASIVE BLADDER CANCER].
    Matsushita M; Kitakaze H; Okada K; Minato N; Mori N; Yoshioka T
    Nihon Hinyokika Gakkai Zasshi; 2018; 109(2):59-67. PubMed ID: 31006743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
    Kulkarni GS; Hermanns T; Wei Y; Bhindi B; Satkunasivam R; Athanasopoulos P; Bostrom PJ; Kuk C; Li K; Templeton AJ; Sridhar SS; van der Kwast TH; Chung P; Bristow RG; Milosevic M; Warde P; Fleshner NE; Jewett MAS; Bashir S; Zlotta AR
    J Clin Oncol; 2017 Jul; 35(20):2299-2305. PubMed ID: 28410011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is bladder wall resection in cancer of the urinary bladder obsolete?].
    Kollwitz AA; Mangel J; Wechsel HW
    Urologe A; 1988 Nov; 27(6):352-5. PubMed ID: 3238838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of partial cystectomy in the treatment of recurrent invasive bladder cancer following radiotherapy.
    Matthews PN; Minton MJ; Haw M; Philip PF
    Br J Urol; 1987 Aug; 60(2):132-5. PubMed ID: 3664203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indications and limitations of radical surgery for cancer of the bladder].
    Marcelli G; Bottanelli A
    Radiol Med; 1983 Nov; 69(11):871-3. PubMed ID: 6677961
    [No Abstract]   [Full Text] [Related]  

  • 20. The Efficacy of Trimodal Chemoradiotherapy with Cisplatin as a Bladder-Preserving Strategy for the Treatment of Muscle-Invasive Bladder Cancer.
    Nagao K; Hara T; Nishijima J; Shimizu K; Fujii N; Kobayashi K; Kawai Y; Inoue R; Yamamoto Y; Matsumoto H; Matsuyama H
    Urol Int; 2017; 99(4):446-452. PubMed ID: 28628910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.